BNP Paribas Financial Markets’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $92.2K | Buy |
|
|||||
|
2025
Q2 | $22.2K | Buy |
|
|||||
|
2025
Q1 | $2.97K | Buy |
|
|||||
|
2024
Q4 | $4.61K | Sell |
|
|||||
|
2024
Q3 | $16.4K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $197 | Buy |
|
|||||
|
2022
Q3 | $81 | Sell |
|
|||||
|
2022
Q2 | $1.21K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $14 | Hold |
|
|||||
|
2020
Q3 | $16 | Hold |
|
|||||
|
2020
Q2 | $11 | Sell |
|
|||||
|
2020
Q1 | $167 | Hold |
|
|||||
|
2019
Q4 | $430 | Sell |
|
|||||
|
2019
Q3 | $5.44K | Hold |
|
|||||
|
2019
Q2 | $6.75K | Sell |
|
|||||
|
2019
Q1 | $12.6K | Buy |
|
|||||
|
2018
Q4 | $767 | Sell |
|
|||||
|
2018
Q3 | $3.59K | Sell |
|
|||||
|
2018
Q2 | $5.31K | Sell |
|
|||||
|
2018
Q1 | $19.7K | Buy |
|
|||||
|
2017
Q4 | $17.6K | Buy |
|
|||||
|
2017
Q3 | $9.09K | Buy |
|
|||||
|
2017
Q2 | $4.6K | Buy |
|
|||||
|
2017
Q1 | $125 | Sell |
|
|||||
|
2016
Q4 | $615 | Sell |
|
|||||
|
2016
Q3 | $3.7K | Buy |
|
|||||
|
2016
Q2 | $1.87K | Buy |
|